<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04556201</url>
  </required_header>
  <id_info>
    <org_study_id>2020-URO-01</org_study_id>
    <nct_id>NCT04556201</nct_id>
  </id_info>
  <brief_title>The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones</brief_title>
  <official_title>A Prospective, Multicenter, Post-Market Clinical Registry to Collect Real-World Evidence on the Clinical Performance of the SOLTIVE™ Laser for Treatment of Kidney or Ureteral Stones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Olympus Corporation of the Americas</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Olympus Corporation of the Americas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect real-world evidence on the performance of the&#xD;
      SOLTIVE™ Premium SuperPulsed Laser System for laser lithotripsy in ureteroscopy, percutaneous&#xD;
      nephrolithotomy (PCNL) and mini PCNL for kidney and ureteral stones.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stone free rate</measure>
    <time_frame>3 month</time_frame>
    <description>Stone free rate as determined by standard of care imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total laser energy time</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured from first to last footswitch press in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>During procedure</time_frame>
    <description>Measured from time of initial ureteroscope insertion to time of ureteroscope withdrawal in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accessory devices used</measure>
    <time_frame>During procedure</time_frame>
    <description>Types of accessory devices used during the procedure (ureteroscopy, PCNL or mini-PCNL) and the total time used during the procedure in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>At procedure, immediate post-procedure, 1 month follow-up and 3 month follow-up</time_frame>
    <description>AEs related to device or procedure and non-serious AEs related to device or procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device deficiencies</measure>
    <time_frame>During procedure</time_frame>
    <description>Number of device deficiencies during the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of treatment/interventions needed</measure>
    <time_frame>At 1 month follow-up and 3 month follow-up</time_frame>
    <description>Types of treatments and/or interventions needed post-procedure at the follow-up visits and the number of times treatments and/or interventions were performed</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Kidney Stone</condition>
  <condition>Ureteral Stone</condition>
  <arm_group>
    <arm_group_label>Thulium Fiber Laser lithotripsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who have a medical indication for ureteroscopy, percutaneous nephrolithotomy (PCNL) or mini PCNL</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SOLTIVE™ Premium SuperPulsed Laser Fiber System</intervention_name>
    <description>SOLTIVE™ SuperPulsed Laser Fiber System and SOLTIVE™ Laser Fibers for single-use only</description>
    <arm_group_label>Thulium Fiber Laser lithotripsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. ≥18 years of age&#xD;
&#xD;
          2. Medical indication for ureteroscopy, percutaneous nephrolithotomy (PCNL) or mini PCNL&#xD;
&#xD;
          3. Willing and able to provide informed consent&#xD;
&#xD;
          4. Female and of childbearing age with a negative pregnancy test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindicated for uteroscopy, PCNL or mini PCNL as determined by the physician&#xD;
&#xD;
          2. Inability to tolerate anesthesia for any reason&#xD;
&#xD;
          3. Unable or unwilling to provide informed consent&#xD;
&#xD;
          4. Concurrently participating in another competing clinical study&#xD;
&#xD;
          5. Known ureteral stricture&#xD;
&#xD;
          6. Unwilling or unable to return for follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ben Chew, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olivier Traxer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tenon Hospital, Sorbonne University, Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephanie Ziegler, BSN, RN</last_name>
    <phone>901-827-2056</phone>
    <email>Stephanie.Ziegler@olympus.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peter Teichmann, PhD</last_name>
    <phone>+49 40 23773 7835</phone>
    <email>Peter.Teichmann@olympus-europa.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mitchell Humphreys, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mitchell R Humphreys, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karen L Stern, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scott M Cheney, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Akin Soner Amasyali</last_name>
    </contact>
    <investigator>
      <last_name>D. Duane Baldwin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joshua Belle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Glavin</last_name>
    </contact>
    <investigator>
      <last_name>Wilson Molina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai West</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Blair Gallante, MPH</last_name>
    </contact>
    <investigator>
      <last_name>Mantu Gupta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johnathan Khusid, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Areeba Sadiq, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alicia Scimeca</last_name>
    </contact>
    <investigator>
      <last_name>Bodo Knudsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Southern Denmark</name>
      <address>
        <city>Fredericia</city>
        <zip>7000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Palle Osther, MD, PhD, MPM</last_name>
    </contact>
    <investigator>
      <last_name>Palle Osther, MD, PhD, MPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital CUF Descobertas</name>
      <address>
        <city>Lisboa</city>
        <zip>1998-018</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Kronenberg, MD</last_name>
    </contact>
    <investigator>
      <last_name>Peter Kronenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Portugal</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World J Urol. 2017 Sep;35(9):1301-1320. doi: 10.1007/s00345-017-2008-6. Epub 2017 Feb 17. Review.</citation>
    <PMID>28213860</PMID>
  </results_reference>
  <results_reference>
    <citation>Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5. doi: 10.1016/j.eururo.2012.03.052. Epub 2012 Mar 31.</citation>
    <PMID>22498635</PMID>
  </results_reference>
  <results_reference>
    <citation>C. Türk, A. Skolarikos, A. Neisius, A. Petrik, C. Seitz, K. Thomas, EAU Guidelines. European Association of Urology (EAU). 2019.</citation>
  </results_reference>
  <results_reference>
    <citation>Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J Urol. 2016 Oct;196(4):1153-60. doi: 10.1016/j.juro.2016.05.090. Epub 2016 May 27.</citation>
    <PMID>27238616</PMID>
  </results_reference>
  <results_reference>
    <citation>Aldoukhi AH, Knudsen BE, Black KM, Hall TL, Roberts WW, Ghani KR. Are We Cutting Ourselves Short? Laser Lithotripsy Performance Based on Differences in Fiber-tip Preparation. Urology. 2019 Dec;134:79-83. doi: 10.1016/j.urology.2019.08.027. Epub 2019 Aug 30.</citation>
    <PMID>31476349</PMID>
  </results_reference>
  <results_reference>
    <citation>Peter Kronenberg, Olivier Traxer. V1718 laser fibers, pulse energy and retropulsion- what we can see and what we can´t. ResearchGate. 2013.</citation>
  </results_reference>
  <results_reference>
    <citation>Humphreys MR, Shah OD, Monga M, Chang YH, Krambeck AE, Sur RL, Miller NL, Knudsen BE, Eisner BH, Matlaga BR, Chew BH. Dusting versus Basketing during Ureteroscopy-Which Technique is More Efficacious? A Prospective Multicenter Trial from the EDGE Research Consortium. J Urol. 2018 May;199(5):1272-1276. doi: 10.1016/j.juro.2017.11.126. Epub 2017 Dec 16.</citation>
    <PMID>29253579</PMID>
  </results_reference>
  <results_reference>
    <citation>Sofer M, Watterson JD, Wollin TA, Nott L, Razvi H, Denstedt JD. Holmium:YAG laser lithotripsy for upper urinary tract calculi in 598 patients. J Urol. 2002 Jan;167(1):31-4.</citation>
    <PMID>11743269</PMID>
  </results_reference>
  <results_reference>
    <citation>Zarrabi A, Gross AJ. The evolution of lasers in urology. Ther Adv Urol. 2011 Apr;3(2):81-9. doi: 10.1177/1756287211400494.</citation>
    <PMID>21869908</PMID>
  </results_reference>
  <results_reference>
    <citation>Kronenberg P, Somani B. Advances in Lasers for the Treatment of Stones-a Systematic Review. Curr Urol Rep. 2018 May 17;19(6):45. doi: 10.1007/s11934-018-0807-y. Review.</citation>
    <PMID>29774438</PMID>
  </results_reference>
  <results_reference>
    <citation>Traxer O, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with Holmium:YAG laser. World J Urol. 2020 Aug;38(8):1883-1894. doi: 10.1007/s00345-019-02654-5. Epub 2019 Feb 6. Review.</citation>
    <PMID>30729311</PMID>
  </results_reference>
  <results_reference>
    <citation>Scott, N. J., C. M. Cilip, and N. M. Fried. Thulium Fiber Laser Ablation of Urinary Stones Through Small-Core Optical Fibers, IEEE Journal of Selected Topics in Quantum Electronics. 2009;(15):435-40.</citation>
  </results_reference>
  <results_reference>
    <citation>Pasqui F, Dubosq F, Tchala K, Tligui M, Gattegno B, Thibault P, Traxer O. Impact on active scope deflection and irrigation flow of all endoscopic working tools during flexible ureteroscopy. Eur Urol. 2004 Jan;45(1):58-64.</citation>
    <PMID>14667517</PMID>
  </results_reference>
  <results_reference>
    <citation>Kronenberg P, Traxer O. The truth about laser fiber diameters. Urology. 2014 Dec;84(6):1301-7. doi: 10.1016/j.urology.2014.08.017.</citation>
    <PMID>25432821</PMID>
  </results_reference>
  <results_reference>
    <citation>Mahmood SN, Toffeq H, Fakhralddin S. Sheathless and fluoroscopy-free retrograde intrarenal surgery: An attractive way of renal stone management in high-volume stone centers. Asian J Urol. 2020 Jul;7(3):309-317. doi: 10.1016/j.ajur.2019.07.003. Epub 2019 Jul 16.</citation>
    <PMID>32742931</PMID>
  </results_reference>
  <results_reference>
    <citation>Enikeev D, Taratkin M, Klimov R, Alyaev Y, Rapoport L, Gazimiev M, Korolev D, Ali S, Akopyan G, Tsarichenko D, Markovina I, Ventimiglia E, Goryacheva E, Okhunov Z, Jefferson FA, Glybochko P, Traxer O. Thulium-fiber laser for lithotripsy: first clinical experience in percutaneous nephrolithotomy. World J Urol. 2020 Dec;38(12):3069-3074. doi: 10.1007/s00345-020-03134-x. Epub 2020 Feb 27.</citation>
    <PMID>32108256</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 7, 2020</study_first_submitted>
  <study_first_submitted_qc>September 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Subject data collected during the study after de-identification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Immediately following publication</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

